INTRA-CELLULAR THERAPIES, INC revenue breakdown overview

INTRA-CELLULAR THERAPIES, INC revenue for the last year amounted to 7.89 B MXN, the most of which — 7.89 B MXN — came from its highest performing source at the moment, Small Molecule Drugs, the year earlier bringing 4.88 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought INTRA-CELLULAR THERAPIES, INC 7.89 B MXN, and the year before that — 4.88 B MXN.